About Us

Archives






CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference

Posted: October 5, 2021 at 6:08 pm


MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Dr. Joseph Sarret, will present a company overview at the H.C. Wainwright 5th Annual NASH Investor Conference, being held virtually on October 12, 2021.

Read more:
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.